vision loss news from FierceBioResearcher
News
Scientists herald "breakthrough" on blindness
British team targets stem cell cure for AMD
A team of British scientists say they can develop a stem cell therapy that will cure blindness caused by age-related macular degeneration within five years. They will use embryonic stem cells to repair damaged retinas. AMD is the leading cause of blindness in the developed world, with some 14 million suffering blindness in Europe as a result of the disease. The London Project to Cure AMD says it has obtained a £4 million donation to recruit leading researchers in the field. And …
Read more...Chemotherapy connected to harsh side effects
New research appearing in the Journal of Biology shows that even low doses of chemotherapy are killing brain cells and cancer drugs are more malignant to healthy cells than diseased cells. The study focused on the effects of cisplatin, cytarabine and carmustine on rats and found that healthy cells were still dying weeks after therapy. And the harsh therapy not only targeted the dividing cells that spread cancer, but normal cells that weren't dividing. The study at the University …
Read more...New stem cell research slows loss of vision
Researchers were able to grow new cells from embryonic stem cells and used them to slow vision loss in rats with a genetic ailment comparable to macular degeneration. The scientists--Raymond D. Lund, who had been at the University of Utah's John A. Moran Eye Center in Salt Lake City, and Robert Lanza of Advanced Cell Technology--say that their work demonstrates the utility of using new cells to substitute for the failing photoreceptor cells in the retina of the eye. Failing photoreceptor …
Read more...Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight

